drugset / Trial / NCT00124930
Study Comparing Olanzapine With Haloperidol for the Relief of Nausea and Vomiting in Patients With Advanced Cancer
Phase 3
Terminated
80 enrolled
Alberta Health services
Canadian Institutes of Health Research (CIHR) · collab
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to compare the efficacy and safety of Haldol (haloperidol) and olanzapine in the control of chronic nausea with advanced cancer patients who have failed first line antiemetic therapy.
Timeline
- Start
- 2005-05
- Primary completion
- 2008-06
- Completion
- 2008-06
Outcome
Outcome not reported
Stopped (Enrollment): “Study suspended due to low enrollment”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Haloperidol | Other / unclassified | — | — |
| Subject | Olanzapine | Small molecule | — | — |